Dice Therapeutics
Pioneering oral solutions to combat chronic diseases in immunology with innovative selective small molecule therapies.
est. 2013
Intract Pharma
Transforming Patient Care by Replacing Injections with Safer, More Effective Therapeutics Given Orally.
14 employees · est. 2016 · London, United Kingdom
Dice Therapeutics is the older company (2013 vs 2016).
1 signal in the last 90 days
Side-by-Side Comparison
| Metric | Dice Therapeutics | Intract Pharma |
|---|---|---|
| Founded | ||
| Founded | 2013 older | 2016 |
| Headquarters | ||
| Headquarters | Not tracked yet | London, United Kingdom |
| Employees | ||
| Employees | Not tracked yet | 14 |
| Industry | ||
| Industry | Biotechnology, Medical Devices | Biotechnology, Life Sciences, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Seed |
| Total Funding | ||
| Total Funding | $532.38M | $420.00K |
| Funding Rounds | ||
| Funding Rounds | 7 | 3 |
| Services | ||
| Services | Not tracked yet | Development of oral drug delivery systems, Biotech drug formulations, Collaborative biopharmaceutical research and development, Preclinical research and trials |
| Target Customers | ||
| Target Customers | Not tracked yet | Pharmaceutical companies, Healthcare providers, Patients requiring biologic therapies, Biotech organizations |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Immunology, Oral Therapies, Chronic Diseases, Small Molecule Therapies, Therapeutic Candidates, DELSCAPE Platform, Protein-protein Interactions, IL-17, Inflammatory Bowel Disease, Idiopathic Pulmonary Fibrosis, Drug Target, Innovative Treatments, Proprietary Technology Platform | Oral Drug Delivery, Biotechnology Innovation, Monoclonal Antibodies, Gastrointestinal Treatment, Immune-mediated Inflammatory Diseases, Phloral™ Technology, Soteria™ Technology, Protein Delivery, Systemic Immunomodulation, Colon Targeted Delivery, Injectable To Oral Conversion, Biologic Medicines, Proprietary Formulation Technologies, University Spin-out, Pharmaceutical Research And Development |
| Website | ||
| Website | dicetherapeutics.com | intractpharma.com |
About Dice Therapeutics
Dice Therapeutics is a biopharmaceutical company founded in 2013, dedicated to pioneering oral solutions for chronic diseases in the field of immunology. The company's slogan reflects its mission of developing innovative selective small molecule therapies to combat these illnesses. Their proprietary...
About Intract Pharma
Intract Pharma is a dynamic biotechnology company committed to advancing patient care by transforming traditional injectable therapies into oral formulations. Founded in 2016 and headquartered in the United Kingdom, the company is pioneering innovations in the oral delivery of complex proteins, part...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Dice Therapeutics and Intract Pharma — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Dice Therapeutics and Intract Pharma — by email.
Frequently Asked Questions
Compare Dice Therapeutics with someone else
Start typing a company name or domain.